A detailed history of Cedar Mountain Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 228 shares of JNJ stock, worth $33,253. This represents 0.01% of its overall portfolio holdings.

Number of Shares
228
Previous 227 0.44%
Holding current value
$33,253
Previous $33,000 9.09%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$145.48 - $167.38 $145 - $167
1 Added 0.44%
228 $36,000
Q2 2024

Jul 11, 2024

BUY
$144.38 - $157.78 $144 - $157
1 Added 0.44%
227 $33,000
Q1 2024

Apr 16, 2024

BUY
$155.22 - $162.74 $155 - $162
1 Added 0.44%
226 $35,000
Q3 2023

Oct 23, 2023

BUY
$155.75 - $174.48 $155 - $174
1 Added 0.45%
225 $35,000
Q2 2023

Jul 19, 2023

BUY
$154.35 - $166.11 $154 - $166
1 Added 0.45%
224 $37,000
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $1,963 - $2,343
13 Added 6.19%
223 $34,000
Q4 2022

Jan 11, 2023

BUY
$160.2 - $179.79 $160 - $179
1 Added 0.48%
210 $37,000
Q3 2022

Oct 11, 2022

BUY
$161.33 - $179.52 $161 - $179
1 Added 0.48%
209 $34,000
Q2 2022

Jul 14, 2022

SELL
$168.19 - $186.01 $6,895 - $7,626
-41 Reduced 16.47%
208 $37,000
Q1 2022

Apr 14, 2022

BUY
$158.14 - $179.59 $158 - $179
1 Added 0.4%
249 $44,000
Q3 2021

Oct 15, 2021

BUY
$161.5 - $179.47 $6,621 - $7,358
41 Added 19.81%
248 $40,000
Q2 2021

Jul 15, 2021

SELL
$159.48 - $171.07 $34,288 - $36,780
-215 Reduced 50.95%
207 $34,000
Q3 2020

Oct 21, 2020

BUY
$140.38 - $153.83 $5,053 - $5,537
36 Added 9.33%
422 $63,000
Q2 2020

Jul 20, 2020

BUY
$128.81 - $155.51 $128 - $155
1 Added 0.26%
386 $54,000
Q1 2020

Apr 27, 2020

SELL
$111.14 - $153.99 $20,560 - $28,488
-185 Reduced 32.46%
385 $51,000
Q4 2019

Jan 30, 2020

BUY
$127.5 - $146.44 $72,675 - $83,470
570 New
570 $83,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.